Literature DB >> 28223152

Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis.

Ping Wang1, Kirk D Jones2, Anatoly Urisman2, Brett M Elicker3, Thomas Urbania3, Kerri A Johannson4, Deborah Assayag4, Joyce Lee4, Paul J Wolters4, Harold R Collard4, Laura L Koth5.   

Abstract

BACKGROUND: The ability of specific histopathologic features to predict mortality or lung transplantation in patients with chronic hypersensitivity pneumonitis (HP) is unknown.
METHODS: Patients with chronic HP diagnosed by surgical lung biopsy were identified from an ongoing longitudinal cohort. The surgical lung biopsy slides were evaluated prospectively by an experienced thoracic pathologist using a standardized checklist to differentiate the major pathologic patterns and score the presence of specific histopathologic features. Cox proportional hazard analysis was used to identify independent predictors of transplant-free survival, and Kaplan-Meier analysis was used to visualize outcomes.
RESULTS: One hundred nineteen patients were identified. Patients with a fibrotic nonspecific interstitial pneumonia (f-NSIP) pattern, bronchiolocentric fibrosis (BF) pattern, or usual interstitial pneumonia (UIP) pattern had significantly worse transplant-free survival than did those with a cellular NSIP (c-NSIP) pattern or peribronchiolar inflammation with poorly formed granulomas (PI-PFG) pattern. No survival difference among patients with an f-NSIP pattern, a BF pattern, or a UIP pattern was found. Fibroblastic foci were identified in a subset of biopsy samples from all pathologic patterns. Peribronchiolar fibrosis was noted in all UIP cases. Independent predictors of time to death or transplantation included the presence of fibroblast foci or dense collagen fibrosis.
CONCLUSIONS: Histopathologic patterns of c-NSIP and PI-PFG had a better transplant-free survival than did patterns of UIP, f-NSIP, and BF. The presence of fibroblast foci or dense collagen fibrosis correlated with progression to death or lung transplantation. Identification of fibroblast foci on biopsy samples, regardless of the underlying histopathologic pattern, may be a clinically useful predictor of survival in patients with HP.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hypersensitivity pneumonitis; lung pathology; prognosis

Mesh:

Year:  2017        PMID: 28223152     DOI: 10.1016/j.chest.2017.02.011

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

1.  Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Hypersensitivity Pneumonitis.

Authors:  Traci N Adams; Chad A Newton; Kiran Batra; Muhanned Abu-Hijleh; Tyonn Barbera; Jose Torrealba; Craig S Glazer
Journal:  Lung       Date:  2018-06-29       Impact factor: 2.584

2.  Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia.

Authors:  Kiminobu Tanizawa; Brett Ley; Eric Vittinghoff; Brett M Elicker; Travis S Henry; Paul J Wolters; Robert Brownell; Shuo Liu; Harold R Collard; Kirk D Jones
Journal:  Histopathology       Date:  2019-04-25       Impact factor: 5.087

3.  Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures.

Authors:  Haruhiko Furusawa; Jonathan H Cardwell; Tsukasa Okamoto; Avram D Walts; Iain R Konigsberg; Jonathan S Kurche; Tami J Bang; Marvin I Schwarz; Kevin K Brown; Jonathan A Kropski; Mauricio Rojas; Carlyne D Cool; Joyce S Lee; Paul J Wolters; Ivana V Yang; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

4.  Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.

Authors:  Julie Morisset; Kerri A Johannson; Kirk D Jones; Paul J Wolters; Harold R Collard; Simon L F Walsh; Brett Ley
Journal:  Am J Respir Crit Care Med       Date:  2017-11-27       Impact factor: 21.405

Review 5.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

Review 6.  Hypersensitivity pneumonitis: new concepts and classifications.

Authors:  Andrew Churg
Journal:  Mod Pathol       Date:  2021-09-16       Impact factor: 7.842

7.  Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management.

Authors:  Gabriela Leuschner; Fredrik Reiter; Florian Stocker; Alexander Crispin; Nikolaus Kneidinger; Tobias Veit; Friederike Klenner; Felix Ceelen; Gregor Zimmermann; Hanno Leuchte; Simone Reu; Julien Dinkel; Jürgen Behr; Claus Neurohr
Journal:  Lung       Date:  2018-05-14       Impact factor: 2.584

8.  Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.

Authors:  Margaret L Salisbury; Tian Gu; Susan Murray; Barry H Gross; Aamer Chughtai; Mohamed Sayyouh; Ella A Kazerooni; Jeffrey L Myers; Amir Lagstein; Kristine E Konopka; Elizabeth A Belloli; Jamie S Sheth; Eric S White; Colin Holtze; Fernando J Martinez; Kevin R Flaherty
Journal:  Chest       Date:  2018-09-19       Impact factor: 9.410

9.  Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis.

Authors:  Fatma Ahmed Tony; Youssef Mohamed Amin Soliman; Hoda A Salem
Journal:  J Asthma Allergy       Date:  2021-05-10

10.  A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.

Authors:  Neal Dodia; Diana Amariei; Blaine Kenaa; Doug Corwin; Lydia Chelala; E James Britt; Ashutosh Sachdeva; Irina G Luzina; Jeffrey D Hasday; Nirav G Shah; Sergei P Atamas; Teri J Franks; Allen P Burke; Stella E Hines; Jeffrey R Galvin; Nevins W Todd
Journal:  Respir Med       Date:  2021-02-11       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.